Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
7,304 total articles
Strategy Inc (MSTR) is effectively a bitcoin treasury wrapped in equity. With roughly 818,334 BTC on the balance sheet valued at $64.14B and a market cap near $64.6B, the stock trades as a near one-for-one play on Bitcoin. For traders who prefer cash over headline volatility, we recommend a tactical short/realization trade: enter at $184.45, target…
Molson Coors (TAP) is trading near its 52-week low after a rough earnings cycle, but free cash flow of $1.17B, an EV/EBITDA of 6.6, and a 4.6% yield make it an asymmetric swing trade. This idea buys the volatility: entry at $41.34, stop at $38.00, primary target $47.00 (mid term) with a longer-term stretch to $55.00 if industry trends normalize.
The Hartford (HIG) trades at roughly $133 and offers a compelling free-cash-flow yield and healthy returns on equity, yet underwriting and revenue growth remain lumpy. This trade idea outlines a mid-term swing long that buys the cash-flow story while protecting against underwriting or macro-driven shocks.
On Holding (ONON) combines durable premium positioning in running and lifestyle footwear with recent margin upgrades and institutional accumulation. The stock is trading nearer its 52-week low while fundamental momentum and technical setups suggest asymmetric upside. This trade idea lays out entry, stop and targets for a long-term position over 180…
Sempra's exposure to Oncor and a reported 127 GW pipeline in Texas creates a levered growth story that the market is under-pricing. With market cap near $61B and EV around $96B, the stock at ~$93 offers upside if Oncor-related projects begin to monetize. We'll lay out an actionable long trade with an entry, stop and target, and the key catalysts an…
Rocket Lab (RKLB) is trading at premium multiples after a record Q1 print and a string of contracts. The shares look overbought technically, but a $2.2B backlog, rising revenue and a clear product roadmap (including the Neutron test in Q4 2026) give me enough conviction to upgrade to Buy with a disciplined entry, stop and target.
Advanced Micro Devices is pricing in rapid AI-driven revenue gains and already shows technical confirmation for another leg higher. Strong Q1 growth in data center and accelerating CPU adoption underpin the thesis, even as valuation is elevated. This is an actionable trade: enter on confirmation, size appropriately, and use a $420 stop to protect a…
Alphabet's core businesses are accelerating again—Google Cloud reported 63% growth and AI revenue jumped ~800% YoY—while the company sits on $64.4B of free cash flow and a $4.66T market cap. Technicals show bullish momentum, but elevated RSI and a potential analyst downgrade pose a near-term risk. This trade idea recommends a controlled long with d…
HUYA is trading below $3.25 despite a resilient business mix, growing engagement signals and a rising short interest that now looks crowded. With a $697M market cap, a demonstrable pattern of shareholder distributions and improving technical momentum, HUYA offers asymmetric upside into $4+ while keeping a tight stop below $2.60. This is a mid-term …
Alphabet (GOOG) is set up to capture AI demand across infrastructure, models, and apps through Google Cloud’s surge and a diversified, high-cash core. This trade targets participation in that multi-front AI story with defined risk controls and a 180-trading-day horizon.
Coherus Oncology (CHRS) is a low-priced, liquid oncology small-cap that recently raised $50.1M and carries a $264M market cap. The stock is trading well below its 52-week high and is heavily shorted, while management directs resources to commercialize LOQTORZI and advance clinical assets. We outline a mid-term trade (45 trading days) to capture pot…
CareTrust REIT (CTRE) remains a compelling buy after recent quarterly performance and portfolio moves. The REIT shows durable growth in revenue and FFO, a conservative balance sheet (debt/equity ~0.22) and a dividend yielding roughly 3.3%. I outline a clear trade: enter at $42.08, stop at $37.00, target $52.00 over a mid-term (45 trading days) hori…
Freshworks (FRSH) has been punished with a deep drawdown even as revenue growth and cash generation improved. At roughly $8.50, the stock offers an attractive entry for a long trade: reasonable near-term upside to $13 if growth stabilizes and sentiment recovers, with a tight stop below the 52-week low to limit downside risk.
Hormel Foods (HRL) looks like a classic income-tilted turnaround: high yield, decent cash generation, and pockets of growth in Foodservice and International. Valuation is modest at roughly $11.1B market cap and 1.4x book, but retail weakness and industry uncertainty keep risk elevated. This trade idea lays out an actionable entry, stop, target and …
Upwork (UPWK) has been punished far more than its fundamentals warrant. The marketplace is profitable, generating $229M in free cash flow and trading at an enterprise multiple under 7x EBITDA. Recent buyback authorization and improving operating metrics argue for a re-rating; I recommend a long trade with a measured stop and a multi-month horizon t…
Algonquin Power & Utilities (AQN) has repositioned into a purer regulated utility and trades at $5.965 with a 4.37% yield. Technicals show short-term weakness but fundamentals point to steadier regulated cash flows and potential re-rating catalysts in 2026. This trade targets a move to the 52-week high at $7.10 over a mid-term horizon while carryin…
Axon has structural SaaS growth and rapid AI adoption that the market is underpricing. Hardware sales compress multiples today, but bookings, 35% software growth, and a raised 2026 revenue guide argue for a long trade on a measured dip. Entry $390, stop $340, target $480 over a 180-trading-day horizon.
Walmart has been grinding higher and now sits in a textbook consolidation that favors continuation. With a higher-low structure, falling volatility, and support near the 50-day zone, a breakout should target new all-time highs. This is a medium-to-long trade idea with specific entry, stop and target levels and a balanced risk framework.
Alliance Resource Partners (ARLP) combines a double-digit yield with strong free cash flow and reasonable leverage. At about $25.30, the stock screens cheap on P/E ~13 and EV/EBITDA ~6.1. This trade idea sets a clearly defined entry, stop, and target for a mid-term swing (45 trading days) that captures a likely near-term re-rating and the May distr…
Charles Schwab ($SCHW) looks better insulated from AI-driven disintermediation than many investors assume. The combination of stable Advisor Services revenue, healthy capital generation (free cash flow $8.76B, cash $10.15B), and a reasonable P/E (~18.6) offers a low-cost entry into a high-quality broker. Trade idea: buy at $90.00, stop $83.00, targ…
Soluna (SLNH) is a small-cap operator pairing renewable generation with compute assets. Recent asset purchases and capacity additions in Texas shine a light on a broader multi-gigawatt pipeline the market is beginning to price in. This trade targets that narrative while sizing risk for negative cash flow and operational execution risk.
Shift4 Payments is trading near its 52-week low while converting sizable revenue growth into free cash flow. Enterprise value multiples look reasonable relative to cash generation even as debt and goodwill remain a material risk. This trade targets a rebound to $65 over the next 180 trading days with a tight stop to respect balance-sheet risk.
Medifast is a $140M market-cap wellness company trading under tangible asset and cash-adjusted valuations. With an enterprise value near $66M, no reported debt, and a low EV/sales multiple, the stock offers asymmetric upside toward a $15 cash-per-share re-rating if management stabilizes coach counts and restores growth. This trade idea lays out an …
RingCentral reported another string of solid operational signals and continues to convert revenue growth into cash. The stock pulled back into the $41-$45 zone offering a tactical entry. This trade targets a move back above the 52-week high into the low $50s over the next 180 trading days while keeping a tight stop beneath the 50-day support band.
Rocket Lab just hit new highs after a blowout quarter and a string of contracts and acquisitions. The fundamentals - record $200M revenue, a $2.2B backlog and low debt - give visibility into growth. But the valuation is already priced for perfection. This trade idea lays out a disciplined, long-biased plan that buys the structural upside while prot…
